Epalrestat Sustained release Tablets 150 mg
📦
COMPOSITION
Each film coated sustained release tablet contains:
Epalrestat IP 150 mg
Excipients q.s.
Approved colour used
PACKAGING
10x10 Alu Alu / Blister
INDICATION & USE
High-quality oral solid dosage pharmaceutical formulation manufactured under WHO-GMP compliance.
Medical Disclaimer
The information provided here is for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. This product is a prescription medication and should only be used under the guidance of a registered medical practitioner.
